LAVANNYA PANDIT to Humans
This is a "connection" page, showing publications LAVANNYA PANDIT has written about Humans.
Connection Strength
0.139
-
Association of Glucose-6-Phosphate Dehydrogenase Deficiency With Outcomes in US Veterans With COVID-19. JAMA Netw Open. 2023 03 01; 6(3):e235626.
Score: 0.021
-
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial. Lancet Infect Dis. 2022 05; 22(5):622-635.
Score: 0.020
-
Admission for COPD Exacerbation Is Associated with the Clinical Diagnosis of Pulmonary Hypertension: Results from a Retrospective Longitudinal Study of a Veteran Population. COPD. 2017 Oct; 14(5):484-489.
Score: 0.014
-
Demographic and clinical features of neuromyelitis optica: A review. Mult Scler. 2015 Jun; 21(7):845-53.
Score: 0.012
-
Autophagy: a new frontier in research in lung diseases. Am J Respir Crit Care Med. 2011 Mar 01; 183(5):566-8.
Score: 0.009
-
The physiologic aggresome mediates cellular inactivation of iNOS. Proc Natl Acad Sci U S A. 2009 Jan 27; 106(4):1211-5.
Score: 0.008
-
Inhibition of BMPER Mitigates Pulmonary Hypertension by Modulating LRP1-YAP Interaction in Smooth Muscle Cells. Arterioscler Thromb Vasc Biol. 2025 Nov; 45(11):2037-2052.
Score: 0.006
-
Treatment of Severe COVID-19 Infection With Remdesivir in Peritoneal Dialysis. J Investig Med High Impact Case Rep. 2023 Jan-Dec; 11:23247096231200386.
Score: 0.005
-
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19. Ann Intern Med. 2022 10; 175(10):1401-1410.
Score: 0.005
-
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial. Ann Intern Med. 2022 02; 175(2):234-243.
Score: 0.005
-
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19. N Engl J Med. 2021 03 11; 384(10):905-914.
Score: 0.005
-
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. N Engl J Med. 2021 01 07; 384(1):20-30.
Score: 0.005
-
Extracellular Vesicles Attenuate Nitrofen-Mediated Human Pulmonary Artery Endothelial Dysfunction: Implications for Congenital Diaphragmatic Hernia. Stem Cells Dev. 2020 08 01; 29(15):967-980.
Score: 0.004
-
Idiopathic pulmonary fibrosis and pulmonary hypertension: Heracles meets the Hydra. Br J Pharmacol. 2021 01; 178(1):172-186.
Score: 0.004
-
Altered Hypoxic-Adenosine Axis and Metabolism in Group III Pulmonary Hypertension. Am J Respir Cell Mol Biol. 2016 Apr; 54(4):574-83.
Score: 0.003
-
Clinical and Immunological Factors in Emphysema Progression. Five-Year Prospective Longitudinal Exacerbation Study of Chronic Obstructive Pulmonary Disease (LES-COPD). Am J Respir Crit Care Med. 2015 Nov 15; 192(10):1171-8.
Score: 0.003
-
Regulation of IL-4 receptor signaling by STUB1 in lung inflammation. Am J Respir Crit Care Med. 2014 Jan 01; 189(1):16-29.
Score: 0.003
-
Src kinase-mediated phosphorylation stabilizes inducible nitric-oxide synthase in normal cells and cancer cells. J Biol Chem. 2010 Jan 01; 285(1):784-92.
Score: 0.002
-
A critical role for CHIP in the aggresome pathway. Mol Cell Biol. 2009 Jan; 29(1):116-28.
Score: 0.002